Skip to Main Content
Skip Nav Destination

Issues

Commentaries

Diabetes April 2015, Vol.64, 1495-1497. doi:https://doi.org/10.2337/db15-0033
Diabetes April 2015, Vol.64, 1498-1499. doi:https://doi.org/10.2337/db14-1910
Diabetes April 2015, Vol.64, 1500-1502. doi:https://doi.org/10.2337/db14-1871
Diabetes April 2015, Vol.64, 1503-1505. doi:https://doi.org/10.2337/db14-1931
Diabetes April 2015, Vol.64, 1506-1508. doi:https://doi.org/10.2337/db14-1901
Diabetes April 2015, Vol.64, 1509-1510. doi:https://doi.org/10.2337/db15-0003
Diabetes April 2015, Vol.64, 1511-1512. doi:https://doi.org/10.2337/db15-0040

Metabolism

Diabetes November 2014, Vol.64, 1513-1521. doi:https://doi.org/10.2337/db14-1176
Diabetes November 2014, Vol.64, 1522-1531. doi:https://doi.org/10.2337/db14-0979
Diabetes November 2014, Vol.64, 1532-1543. doi:https://doi.org/10.2337/db14-0827
Diabetes December 2014, Vol.64, 1544-1554. doi:https://doi.org/10.2337/db14-1125
Diabetes December 2014, Vol.64, 1555-1563. doi:https://doi.org/10.2337/db14-1279
Diabetes December 2014, Vol.64, 1564-1575. doi:https://doi.org/10.2337/db14-1391
Diabetes December 2014, Vol.64, 1576-1590. doi:https://doi.org/10.2337/db14-1180
Diabetes December 2014, Vol.64, 1591-1602. doi:https://doi.org/10.2337/db14-1368
Diabetes December 2014, Vol.64, 1603-1614. doi:https://doi.org/10.2337/db14-0970
Diabetes December 2014, Vol.64, 1615-1620. doi:https://doi.org/10.2337/db14-0961

Obesity Studies

Diabetes November 2014, Vol.64, 1621-1631. doi:https://doi.org/10.2337/db14-0645
Diabetes January 2015, Vol.64, 1632-1642. doi:https://doi.org/10.2337/db14-1132
Diabetes December 2014, Vol.64, 1643-1657. doi:https://doi.org/10.2337/db14-1050
Diabetes December 2014, Vol.64, 1658-1669. doi:https://doi.org/10.2337/db14-0631
Diabetes January 2015, Vol.64, 1670-1681. doi:https://doi.org/10.2337/db14-1127

Islet Studies

Diabetes November 2014, Vol.64, 1682-1687. doi:https://doi.org/10.2337/db14-1370
Diabetes December 2014, Vol.64, 1688-1697. doi:https://doi.org/10.2337/db14-1051
Diabetes December 2014, Vol.64, 1698-1702. doi:https://doi.org/10.2337/db14-1675

Immunology and Transplantation

Diabetes December 2014, Vol.64, 1703-1712. doi:https://doi.org/10.2337/db13-1798
Diabetes December 2014, Vol.64, 1713-1718. doi:https://doi.org/10.2337/db14-1620

Pathophysiology

Diabetes December 2014, Vol.64, 1719-1727. doi:https://doi.org/10.2337/db14-0497

Complications

Diabetes November 2014, Vol.64, 1728-1742. doi:https://doi.org/10.2337/db14-0758
Diabetes December 2014, Vol.64, 1743-1759. doi:https://doi.org/10.2337/db14-0719
Diabetes December 2014, Vol.64, 1760-1769. doi:https://doi.org/10.2337/db14-1359
Diabetes December 2014, Vol.64, 1770-1779. doi:https://doi.org/10.2337/db14-1445

Pharmacology and Therapeutics

Diabetes December 2014, Vol.64, 1780-1785. doi:https://doi.org/10.2337/db14-1018
Diabetes December 2014, Vol.64, 1786-1793. doi:https://doi.org/10.2337/db14-1388
Diabetes January 2015, Vol.64, 1794-1803. doi:https://doi.org/10.2337/db14-0635
Diabetes December 2014, Vol.64, 1804-1817. doi:https://doi.org/10.2337/db14-1423

Genetics / Genomes / Proteomics / Metabolomics

Diabetes November 2014, Vol.64, 1818-1829. doi:https://doi.org/10.2337/db14-1497
Philippa J. Talmud; on behalf of the UCLEB Consortium; Jackie A. Cooper; on behalf of the UCLEB Consortium; Richard W. Morris; on behalf of the UCLEB Consortium; Frank Dudbridge; on behalf of the UCLEB Consortium; Tina Shah; on behalf of the UCLEB Consortium; Jorgen Engmann; on behalf of the UCLEB Consortium; Caroline Dale; on behalf of the UCLEB Consortium; Jon White; on behalf of the UCLEB Consortium; Stela McLachlan; on behalf of the UCLEB Consortium; Delilah Zabaneh; on behalf of the UCLEB Consortium; Andrew Wong; on behalf of the UCLEB Consortium; Ken K. Ong; on behalf of the UCLEB Consortium; Tom Gaunt; on behalf of the UCLEB Consortium; Michael V. Holmes; on behalf of the UCLEB Consortium; Debbie A. Lawlor; on behalf of the UCLEB Consortium; Marcus Richards; on behalf of the UCLEB Consortium; Rebecca Hardy; on behalf of the UCLEB Consortium; Diana Kuh; on behalf of the UCLEB Consortium; Nicholas Wareham; on behalf of the UCLEB Consortium; Claudia Langenberg; on behalf of the UCLEB Consortium; Yoav Ben-Shlomo; on behalf of the UCLEB Consortium; S. Goya Wannamethee; on behalf of the UCLEB Consortium; Mark W.J. Strachan; on behalf of the UCLEB Consortium; Meena Kumari; on behalf of the UCLEB Consortium; John C. Whittaker; on behalf of the UCLEB Consortium; Fotios Drenos; on behalf of the UCLEB Consortium; Mika Kivimaki; on behalf of the UCLEB Consortium; Aroon D. Hingorani; on behalf of the UCLEB Consortium; Jacqueline F. Price; on behalf of the UCLEB Consortium; Steve E. Humphries; on behalf of the UCLEB Consortium
Diabetes December 2014, Vol.64, 1830-1840. doi:https://doi.org/10.2337/db14-1504
Tove Fall; on behalf of the ENGAGE Consortium; Sara Hägg; on behalf of the ENGAGE Consortium; Alexander Ploner; on behalf of the ENGAGE Consortium; Reedik Mägi; on behalf of the ENGAGE Consortium; Krista Fischer; on behalf of the ENGAGE Consortium; Harmen H.M. Draisma; on behalf of the ENGAGE Consortium; Antti-Pekka Sarin; on behalf of the ENGAGE Consortium; Beben Benyamin; on behalf of the ENGAGE Consortium; Claes Ladenvall; on behalf of the ENGAGE Consortium; Mikael Åkerlund; on behalf of the ENGAGE Consortium; Mart Kals; on behalf of the ENGAGE Consortium; Tõnu Esko; on behalf of the ENGAGE Consortium; Christopher P. Nelson; on behalf of the ENGAGE Consortium; Marika Kaakinen; on behalf of the ENGAGE Consortium; Ville Huikari; on behalf of the ENGAGE Consortium; Massimo Mangino; on behalf of the ENGAGE Consortium; Aline Meirhaeghe; on behalf of the ENGAGE Consortium; Kati Kristiansson; on behalf of the ENGAGE Consortium; Marja-Liisa Nuotio; on behalf of the ENGAGE Consortium; Michael Kobl; on behalf of the ENGAGE Consortium; Harald Grallert; on behalf of the ENGAGE Consortium; Abbas Dehghan; on behalf of the ENGAGE Consortium; Maris Kuningas; on behalf of the ENGAGE Consortium; Paul S. de Vries; on behalf of the ENGAGE Consortium; Renée F.A.G. de Bruijn; on behalf of the ENGAGE Consortium; Sara M. Willems; on behalf of the ENGAGE Consortium; Kauko Heikkilä; on behalf of the ENGAGE Consortium; Karri Silventoinen; on behalf of the ENGAGE Consortium; Kirsi H. Pietiläinen; on behalf of the ENGAGE Consortium; Vanessa Legry; on behalf of the ENGAGE Consortium; Vilmantas Giedraitis; on behalf of the ENGAGE Consortium; Louisa Goumidi; on behalf of the ENGAGE Consortium; Ann-Christine Syvänen; on behalf of the ENGAGE Consortium; Konstantin Strauch; on behalf of the ENGAGE Consortium; Wolfgang Koenig; on behalf of the ENGAGE Consortium; Peter Lichtner; on behalf of the ENGAGE Consortium; Christian Herder; on behalf of the ENGAGE Consortium; Aarno Palotie; on behalf of the ENGAGE Consortium; Cristina Menni; on behalf of the ENGAGE Consortium; André G. Uitterlinden; on behalf of the ENGAGE Consortium; Kari Kuulasmaa; on behalf of the ENGAGE Consortium; Aki S. Havulinna; on behalf of the ENGAGE Consortium; Luis A. Moreno; on behalf of the ENGAGE Consortium; Marcela Gonzalez-Gross; on behalf of the ENGAGE Consortium; Alun Evans; on behalf of the ENGAGE Consortium; David-Alexandre Tregouet; on behalf of the ENGAGE Consortium; John W.G. Yarnell; on behalf of the ENGAGE Consortium; Jarmo Virtamo; on behalf of the ENGAGE Consortium; Jean Ferrières; on behalf of the ENGAGE Consortium; Giovanni Veronesi; on behalf of the ENGAGE Consortium; Markus Perola; on behalf of the ENGAGE Consortium; Dominique Arveiler; on behalf of the ENGAGE Consortium; Paolo Brambilla; on behalf of the ENGAGE Consortium; Lars Lind; on behalf of the ENGAGE Consortium; Jaakko Kaprio; on behalf of the ENGAGE Consortium; Albert Hofman; on behalf of the ENGAGE Consortium; Bruno H. Stricker; on behalf of the ENGAGE Consortium; Cornelia M. van Duijn; on behalf of the ENGAGE Consortium; M. Arfan Ikram; on behalf of the ENGAGE Consortium; Oscar H. Franco; on behalf of the ENGAGE Consortium; Dominique Cottel; on behalf of the ENGAGE Consortium; Jean Dallongeville; on behalf of the ENGAGE Consortium; Alistair S. Hall; on behalf of the ENGAGE Consortium; Antti Jula; on behalf of the ENGAGE Consortium; Martin D. Tobin; on behalf of the ENGAGE Consortium; Brenda W. Penninx; on behalf of the ENGAGE Consortium; Annette Peters; on behalf of the ENGAGE Consortium; Christian Gieger; on behalf of the ENGAGE Consortium; Nilesh J. Samani; on behalf of the ENGAGE Consortium; Grant W. Montgomery; on behalf of the ENGAGE Consortium; John B. Whitfield; on behalf of the ENGAGE Consortium; Nicholas G. Martin; on behalf of the ENGAGE Consortium; Leif Groop; on behalf of the ENGAGE Consortium; Tim D. Spector; on behalf of the ENGAGE Consortium; Patrik K. Magnusson; on behalf of the ENGAGE Consortium; Philippe Amouyel; on behalf of the ENGAGE Consortium; Dorret I. Boomsma; on behalf of the ENGAGE Consortium; Peter M. Nilsson; on behalf of the ENGAGE Consortium; Marjo-Riitta Järvelin; on behalf of the ENGAGE Consortium; Valeriya Lyssenko; on behalf of the ENGAGE Consortium; Andres Metspalu; on behalf of the ENGAGE Consortium; David P. Strachan; on behalf of the ENGAGE Consortium; Veikko Salomaa; on behalf of the ENGAGE Consortium; Samuli Ripatti; on behalf of the ENGAGE Consortium; Nancy L. Pedersen; on behalf of the ENGAGE Consortium; Inga Prokopenko; on behalf of the ENGAGE Consortium; Mark I. McCarthy; on behalf of the ENGAGE Consortium; Erik Ingelsson; on behalf of the ENGAGE Consortium
Diabetes February 2015, Vol.64, 1841-1852. doi:https://doi.org/10.2337/db14-0988
Diabetes December 2014, Vol.64, 1853-1866. doi:https://doi.org/10.2337/db14-0732

Issues and Events

Diabetes April 2015, Vol.64, 1867. doi:https://doi.org/10.2337/db15-ie05

E-Letters: Comments and Responses

Diabetes April 2015, Vol.64, e5. doi:https://doi.org/10.2337/db14-1633
Diabetes April 2015, Vol.64, e6. doi:https://doi.org/10.2337/db14-1676
Close Modal

or Create an Account

Close Modal
Close Modal